PP
LJPC

PDT Partners’s La Jolla Pharmaceutical Company LJPC Stock Holding History

PDT Partners’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,585
Closed -$45K – 988
2021
Q2 		$45K Sell
10,585
-224
-2% -$960 ﹤0.01% 775
2021
Q1 		$46K Buy
+10,809
New +$59.6K ﹤0.01% 756
2020
Q2 		– Sell
-110,300
Closed -$463K – 898
2020
Q1 		$463K Buy
110,300
+27,936
+34% +$176K 0.04% 393
2019
Q4 		$324K Buy
82,364
+22,822
+38% +$135K 0.02% 522
2019
Q3 		$524K Buy
+59,542
New +$563K 0.03% 336

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return

PDT Partners's LJPC Position: Q3 2021 in Review

PDT Partners sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2021, closing a stake of 10,585 shares — an estimated $45K sold.

PDT Partners first reported a position in LJPC in Q3 2019 and held it in 5 quarters. The position peaked at $524K in Q3 2019. 54 funds tracked by Wall St. Rank hold LJPC as of Q3 2021.

  • PDT Partners reported no remaining La Jolla Pharmaceutical Company position as of Q3 2021 after selling out during the quarter.
  • PDT Partners sold 10,585 La Jolla Pharmaceutical Company shares in Q3 2021, an estimated $45K.
  • PDT Partners first reported a position in La Jolla Pharmaceutical Company in Q3 2019 and held it in 5 quarters.
  • PDT Partners's La Jolla Pharmaceutical Company position peaked at $524K in Q3 2019.
  • 54 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2021.

Based on PDT Partners's 13F filing for Q3 2021, filed 15 Nov 2021.